Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]NAV4694 PET in Alzheimer's Disease and Healthy Volunteers
NCT01680588Phase 2Unknown
- Sponsor
- Navidea Biopharmaceuticals, Inc.
- Start
- Aug 2012
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
A Phase 2 trial of flutafuranol in Alzheimer's disease (AD), sponsored by Navidea Biopharmaceuticals, Inc.. Status: unknown.
02
Drugs
flutafuranol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01680588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01680588.